Novell

What Novell does

Novell Pharmaceutical Laboratories (PT. Novell Pharmaceutical Laboratories) is an Indonesian pharmaceutical manufacturer founded in 1998 and headquartered in Jakarta Barat, with a GMP-compliant manufacturing plant in Bogor spanning approximately 2 hectares. The company develops, produces, and distributes a broad portfolio of more than 150 branded pharmaceutical and consumer health products spanning antibiotics, antivirals, cardiovascular and hematopoietic, central nervous system and psychiatry, dermatology, gastrointestinal, hormones, metabolism (including antidiabetics), neuromuscular, respiratory, vitamins and minerals, women's health, baby care (PureBB, PureKids, ProBaby, PureMom lines), and nutritional supplements — covering both injectable and oral solid dosage forms. Quality assurance is anchored by more than 35 HPLC, LCMS-MS, and UPLC screening instruments and equipment from international vendors including Bausch & Stroebel, LYTZEN, GETINGE, CARRIER, and RO-EDI CHRIST.

The business is organized around two principal commercial divisions — an Ethical/Prescription division and an OTC-Consumer division — plus a Manufacturing division, supported by a direct field sales force of more than 1,500 personnel (as of June 2013) covering almost all of Indonesia with Medical Representatives, Sales Promotion Officers, Supervisors, Area Sales Managers, and Event Promotion Executives. Internationally, the company operates own offices and marketing teams in the Philippines, Thailand, and Vietnam. Customers are categorized as patients seeking affordable treatment, the medical community and healthcare providers requiring quality products and medical information, and government healthcare programs. Distribution is exclusively direct field sales for the domestic market and own-country sales/marketing entities for international markets; pricing is not publicly disclosed.

Novell's principal sources of differentiation are international regulatory certifications: it is the first Indonesian local pharmaceutical company to obtain GMP approval from an EU authority (Germany - LAGeSo, 2013) for its injectable plant, and in 2017 became the first Indonesian company to obtain drug approval from the EU Netherland Authority CBG/MEB. It also holds regulatory approvals from the Australian TGA (2011), GCC (2009), South Africa MCC (2009), UAE (2009), Kenya (2010), and Turkey (2011). The company is additionally certified to bpom and ISO 9001, and holds Halal certification from MUI. No public listing, external funding rounds, M&A activity, or disclosed revenue figures are present in the available data, indicating an independent private operating company of mid-tier scale in the Indonesian pharmaceutical sector.

Name

Novell

Legal name

PT. Novell Pharmaceutical Laboratories

Website

https://novellpharm.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Novell Pharmaceutical Laboratories is an Indonesian pharmaceutical manufacturer founded in 1998 that produces and distributes a broad portfolio of generic prescription, OTC, baby care, and nutritional supplement products across multiple therapeutic categories, serving patients, healthcare providers, and government programs via a 1,500+ strong domestic field sales force and own offices in the Philippines, Thailand, and Vietnam.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)

Keywords

• Pharmaceutical manufacturing
• Prescription medications
• Over-the-counter products
• Baby and maternal care
• Nutritional supplements

Headquarters

HQ city

Dki Jakarta

HQ country

Indonesia

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Novell generates revenue through manufacturing and selling pharmaceutical products across multiple therapeutic categories including antibiotics, cardiovascular, CNS, respiratory, gastrointestinal, and consumer health products. Products are sold through ethical (prescription), OTC-Consumer, and manufacturing division channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Novell Pharmaceutical Laboratories manufactures and sells a comprehensive portfolio of pharmaceutical products across prescription (Ethical) and OTC-Consumer categories, spanning antibiotics, antivirals, allergy, cardiovascular, CNS/psychiatry, dermatology, gastrointestinal, hormones, metabolism, neuromuscular, respiratory, vitamins/minerals, and women's health therapeutic areas. The company also operates dedicated product lines for baby and maternal care (PUREBB, PureKids, ProBaby, PureMom), nutritional supplements (Nutrafor line), and cosmetics/personal care (Hygina), producing both injectable and oral solid dosage forms at a GMP-compliant 2-hectare facility in Bogor for sale primarily through its own field sales force across Indonesia and select Southeast Asian markets.

Product overview

Novell Pharmaceutical Laboratories (PT. Novell Pharmaceutical Laboratories) is an Indonesian pharmaceutical manufacturer producing a comprehensive portfolio of prescription medications, over-the-counter products, baby care items, and nutritional supplements. The product portfolio spans multiple therapeutic categories including Allergy & Immune System (Destavell, Folerin, Ryvel), Antibiotics (Azivol, Novamox, Levores), Antivirals (Cyclovid, Herax), Cardiovascular & Hematopoietic System (Amlocor, Bisovell, Trombufit), Central Nervous System & Psychiatry (Cholinaar, Noprenia, Frixitas), Dermatology (Stardine, Flexamine Cream), Gastrointestinal (Ezocon, Omevell, LACTOFID), Hormones (Novestrol, Pinfetil), Metabolism (Glucovel, Metphar-XR), Neuromuscular System (Velcox, Notrixum), Respiratory System (Ataroc, Friventil), Vitamins & Minerals (Caloma, Vitamam), and Women's Health (Dienovel, Prolacta, Stretchwell). The company also operates dedicated product lines for baby and children's care (PUREBB, PureKids, ProBaby, PureMom) and cosmetics/personal care (Hygina). Novell manufactures both injectable and oral solid dosage forms, with regulatory approvals from multiple international authorities including EU, Australia, and various Asian and African countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription (Ethical) Pharmaceutical Portfolio A comprehensive portfolio of prescription pharmaceutical products spanning multiple therapeutic categories including allergy and immune system (Destavell, Folerin, Meclovel, Prosix, Ryvel, Ryvel Plus), antibiotics (Azivol, Aztercon, Civell, Levores, Lincovel, Macrosan, Novamox, Novlx, Rilex, Solmex, Sultamicillin, Trovafloxacin), antivirals (Cyclovid, Daunocin, Fapivell, Herax, Zostavir), cardiovascular and hematopoietic system (Amlocor, Nidaven, Angintriz MR, Bisovell, Candotens, Co-Irvell, Epotrex, Haemostop, Iruvell, Nodit, Ranovell, Roxemid, Somanovell, Trombufit), CNS/psychiatry (Cholinaar, Donacept, Meconeuro, Lazostin, Barzepin, Epiven, Eterlox, Glinov, Alena, Icunes, Miloz, Sedares, Mirzap, Noprenia, Quetvell, Sopavel, Zipren, Depram, Sernade, Frixitas, Zolta), dermatology (Stardine, Flexamine Cream, MIPI, Fenavel), gastrointestinal (Ezocon, Lanvell, Myllacid, Omevell, Peptifat, Constuloz, Flemavel, LACTOFID, Nesfol, Clopramel, Lazafin, Monell, Granovell, Ondavell, RAMOZEA, Livapro SS, Livell, Ornispar, Urlicon), genito-urinary (Enatin, Nexurin, PROSTAM SR, Reinpid), hormones (Egoji, Nodevex, Novestrol, Trilac, Tiavell, Velthrom, Pinfetil), anesthetics/antiseptics (Antipac, DEXTRON, OFERLOD, Gotik, Isonest, Lignovell, NOREVELL, NOTRIXUM), bone health (Alovell, Bonevell), antidiabetic (Glucovel, Metphar-XR, Tazovell, Velacom Plus), neuromuscular (Etorvel, Nazovel, Novemax, Velcox, Zitanid, Noveron, Diklovit, Menin Forte, Pinorec, Pyrex, Voxib, Xevolac), respiratory (Dicom, Vaporin, Nosfocin, Oksovell, Ataroc, Friventil, Glitaven, Velutine, Cooling-5), vitamins/minerals (Ardivit PL, Ascorvell, AstatIN, C2FIT, Dialifer, Eazycal, Elovess, Fermom, Ferro-K, Foremic, IMUNKID, Neurofort, Novelysin, Ostobon, Ostogard, Oxyvell, Postovit, Sanosin, Teorol, Zamel, Zyfro), oncology (Metvell, Noprostol, Oxyla, Proterine), and women's health (Caloma, Dienovel, Prolacta, Stretchwell, Vitamam, Hygina, Lactamam, Nipvell, NSC, Care Plus, Clidiaz, Ericfil, Fertitest, Fitamino). Sold to healthcare providers through the Medical Representative Ethical sales force.
• PUREBB Baby Care Line A line of baby care products including PureBB Cleanser (cleansing product for babies), PureBB Cream (skincare cream for babies), PureBB Lotion (moisturizing lotion for babies) and PureBB Shampoo (hair cleansing product for babies). Targeted at parents of infants seeking branded baby care products.
• PureKids Children's Healthcare Line A product line for children's healthcare needs, including the IMUNKID immune support supplement for children, marketed under the PureKids brand. Targeted at parents of young children seeking trusted children's health products.
• ProBaby Baby Health & Wellness Line The ProBaby baby health and wellness product line from Novell, covering products targeted at baby health and nutritional supplementation needs. Sold through consumer retail channels including pharmacies and baby stores.
• PureMom Maternal Care Line A maternal care product line for mothers including supplements and care products such as Vitamam (prenatal vitamin supplement), Caloma (prenatal vitamin supplement for pregnant women), Prolacta (lactation support supplement for breastfeeding mothers), Lactamam (lactation support supplement), Nipvell (nipple care product for breastfeeding mothers), Fermom (iron supplement for pregnancy), Postovit (postpartum supplement), Stretchwell (dermatological product for scar and stretch mark treatment), Care Plus, NSC (women's health nutritional supplement) and Nutrafor Meno (menopause support supplement). Targeted at mothers and expectant mothers.
• Nutrafor Nutritional Supplement Line The Nutrafor family of nutritional supplements including Nutrafor (general nutritional supplement line), Nutrafor Gluco (glucose support nutritional supplement), Nutrafor Wazzir (herbal nutritional supplement), Nutrafor Meno (menopause support supplement), BIOGEL (nutritional supplement gel), VILLIUS (nutritional supplement), Acyfote (dietary supplement), Colavell (collagen supplement), Omek (dietary supplement), Xevolac (pain management) and other supplements including Ascorvell, C2FIT, Dialifer, Foremic, Novelysin, Ostobon, Ostogard, Elovess, Sanosin, Teorol, Zamel and Zyfro. Targeted at consumers seeking self-administered nutritional support.
• Hygina Personal Care Product Hygina is a personal hygiene and feminine care product offered under Novell's consumer/cosmetics category, targeted at women seeking feminine hygiene solutions.

Quantifiable outcome

• First Indonesian Local Pharmaceutical company to obtain GMP approval from European Union authority (Germany - Lageso) for its injectable plant
• +1 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Sun Pharmaceutical Industries: India's largest specialty generics manufacturer with broad therapeutic coverage and increasing presence in Southeast Asian emerging markets. Comparable to Novell in broad-spectrum generic manufacturing, multi-country emerging-market distribution, and growing regulatory footprint — but at vastly greater scale.
• Cipla Limited: India-based global pharmaceutical company with strong respiratory, cardiovascular, and CNS generic portfolios, active in emerging markets including Southeast Asia. Comparable to Novell in therapeutic categories served (allergy/respiratory, cardiovascular, CNS) and presence in Indonesia and ASEAN markets.

Direct peers

• PT Kalbe Farma Tbk: Indonesia's largest pharmaceutical company, manufacturing and distributing prescription, OTC, consumer health, and nutrition products across Indonesia and ASEAN. Closely comparable to Novell in business model (vertically integrated pharma manufacturer-distributor), therapeutic breadth, and Indonesian-centric field sales coverage, though operating at much larger scale.
• Dexa Medica: Indonesian pharmaceutical group manufacturing branded generics across multiple therapeutic categories with strong Indonesia field-sales presence and active export business. Highly comparable to Novell in vertically integrated model, generic-focused broad portfolio, and Indonesian field-force-led go-to-market.
• PT Sanbe Farma: Indonesian pharmaceutical manufacturer producing a broad range of finished dosage forms across multiple therapeutic categories with GMP-certified plants. Highly comparable to Novell in therapeutic breadth, GMP manufacturing capability, and Indonesia field-sales model.
• PT Kimia Farma Tbk: Indonesian state-owned pharmaceutical manufacturer and one of the largest pharmacy operators in Indonesia, producing prescription and OTC drugs across broad therapeutic categories. Comparable to Novell in manufacturing footprint, broad-line portfolio, and Indonesia-centric distribution, with the addition of a retail pharmacy chain.
• PT Tempo Scan Pacific Tbk: Indonesian listed pharma and consumer health company manufacturing prescription pharmaceuticals, OTC, and personal care products with established distribution across Indonesia. Compares to Novell in broad-line pharmaceutical manufacturing with both ethical and OTC/consumer divisions.
• PT Pharos Indonesia: Indonesian pharmaceutical company producing branded generics and consumer health products with both prescription and OTC divisions. Closely comparable to Novell in product portfolio breadth, ethical/OTC dual channel strategy, and Indonesia-centric operations.
• Mensa Group (PT Mensa Bina Sukses): Indonesian pharmaceutical and consumer healthcare company manufacturing and marketing a broad range of prescription and OTC products with significant field sales coverage. Compares to Novell in therapeutic diversity, manufacturing scale, and Indonesian field-driven GTM.
• PT Indofarma (Persero) Tbk: Indonesian state-owned pharmaceutical manufacturer producing prescription, OTC, and consumer health products with national distribution. Comparable to Novell as a domestic Indonesian manufacturer of broad-line pharmaceuticals serving both government health programs and retail channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/NovellCareer

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novell